Home » Topics » BioWorld Science

BioWorld Science
RSS

GSK initiates phase II study of SARM GSK-2881078 in patients with COPD

April 3, 2018

NIAID initiates phase I study of HIV-1 vaccines

April 3, 2018

FN-1501 identified as a novel FLT-3 and CDK inhibitor for the treatment of AML

April 3, 2018

C4X licenses orexin-1 receptor antagonist C4X-3256 to Indivior

March 29, 2018

Redx suspends enrollment in phase I/IIa study of RXC-004

March 29, 2018

Zeria Pharmaceutical applies for approval of Z-213 in Japan

March 29, 2018

Takeda considers making offer for Shire

March 29, 2018

Janssen files for approval of apalutamide in Japan

March 29, 2018

Prometic Life Sciences offers new data from phase II study of PBI-4050 in Alstrom syndrome

March 29, 2018

METTL3 linked to hepatocellular carcinogenesis

March 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...